Reference
  1. WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. Geneva: World Health Organization, March 11, 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening- remarks-at-the-media briefing-on-covid-19—11-march-2020 (accessed April 20, 2020)
  2. Mantovani A, Rinaldi E, Zusi C, et al. Coronavirus disease 2019(COVID-19) in children and/or adolescents: a meta-analysis. Pediatr Res. 2020.
  3. Mehta NS, Mytton OT, Mullins EWS, Fowler TA, Falconer CL, Murphy OB, et al. SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review. Clin Infect Dis. 2020 Dec 3;71(9):2469-2479.
  4. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335-37.
  5. Katharine Orf et al. Remdesivir during induction chemotherapy for newly
diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection. British Journal of Haematology. 2020, 190, e268–e288.
  1. Marcia M et al. Acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19. Pediatr Blood Cancer. 2020;e28423.
  2. Benoît Bernar et al. SARS-CoV-2 infection in a 7-year-old girl with pancytopenia during acute lymphocytic leukemia maintenance therapy. Pediatr Blood Cancer. 2020;e28391.
  3. Venkatraman Radhakrishnan and Devleena Gangopadhyay. Repeat-positive SARS-CoV-2 in a child with cancer. Pediatr Blood Cancer. 2020;e28744.
  4. Leclercq et al. Pediatric Acute B-Cell Lymphoblastic Leukemia Developing
Following Recent SARS-CoV-2 Infection. J Pediatr Hematol Oncol. Volume 00, Number 00, 2021.
Yogindra Persaud et al. Childhood B-Cell Acute Lymphoblastic Leukemia
Following SARS CoV-2 Infection: A Potential Second “Hit” in Leukemogenesis. J Pediatr Hematol Oncol. Volume 00, Number 00, 2020.
Le Bert N, Tan AT, Kunasegaran K, et al. SARS-CoV-2-specifc T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature.
2020;584(7821):457–62.
Bakhtawar N, Usman M, Khan MMU. Convalescent plasma therapy and
its efects on COVID-19 patient outcomes: a systematic review of current
literature. Cureus. 2020;12(8):e9535.
Greaves M. A causal mechanism for childhood acute lymphoblastic
leukaemia. Nat Rev Cancer. 2018;18:471-484.
Taub JW, Konrad MA, Ge Y, et al. High frequency of leukemic clones in
newborn screening blood samples of children with B-precursor acute
lymphoblastic leukemia. Blood. 2002;99:2992-2996